These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 31437034)
1. Infantile haemangioma: topical timolol gel may be safer in premature babies. Paul SP; Davis RF Br J Hosp Med (Lond); 2019 Aug; 80(8):i. PubMed ID: 31437034 [No Abstract] [Full Text] [Related]
2. Tufted angioma successfully treated with topical timolol gel-forming solution. Behera B; Remya R; Chandrashekar L; Thappa DM; Gochhait D Indian J Dermatol Venereol Leprol; 2021 [SEASON]; 87(4):581-584. PubMed ID: 34219431 [No Abstract] [Full Text] [Related]
3. Comparison of Two Formulations of Topical Timolol for the Treatment of Infantile Hemangiomas. Ng MSY; Tay YK; Ng SS; Foong AYW; Koh MJ Pediatr Dermatol; 2017 Jul; 34(4):492-493. PubMed ID: 28543755 [TBL] [Abstract][Full Text] [Related]
4. Topical timolol 0.5% gel-forming solution for small deep facial infantile hemangiomas. Sorrell J; Chamlin SL Pediatr Dermatol; 2013; 30(5):592-4. PubMed ID: 23889228 [TBL] [Abstract][Full Text] [Related]
11. Imiquimod 5% cream versus timolol 0.5% ophthalmic solution for treating superficial proliferating infantile haemangiomas: a retrospective study. Qiu Y; Ma G; Yang J; Hu X; Chen H; Jin Y; Lin X Clin Exp Dermatol; 2013 Dec; 38(8):845-50. PubMed ID: 23627540 [TBL] [Abstract][Full Text] [Related]
12. The Role of Topical Timolol in the Treatment of Infantile Hemangiomas: A Systematic Review and Meta-analysis. Khan M; Boyce A; Prieto-Merino D; Svensson Å; Wedgeworth E; Flohr C Acta Derm Venereol; 2017 Nov; 97(10):1167-1171. PubMed ID: 28421234 [TBL] [Abstract][Full Text] [Related]
13. Doing the math: A simple approach to topical timolol dosing for infantile hemangiomas. Dalla Costa R; Prindaville B; Wiss K Pediatr Dermatol; 2018 Mar; 35(2):276-277. PubMed ID: 29315812 [TBL] [Abstract][Full Text] [Related]
14. Topical timolol treatment for periocular infantile haemangioma in the developing world. Jefferson RJ; Hildebrand GD Trop Doct; 2019 Jul; 49(3):246-248. PubMed ID: 31014195 [TBL] [Abstract][Full Text] [Related]
15. Episcleral infantile hemangioma successfully treated with topical timolol. Ciudad Blanco C; Campos Domínguez M; Moreno García B; Villanueva Álvarez-Santullano CA; Berenguer Fröhner B; Suárez Fernández R Dermatol Ther; 2015; 28(1):22-4. PubMed ID: 25286087 [TBL] [Abstract][Full Text] [Related]
16. A prospective self-controlled study of topical timolol 0.5% cream for large superficial infantile hemangiomas. Qiu Y; Yang J; Chen M; Chang L; Wang T; Ma G; Jin Y; Chen H; Lin X J Dermatol; 2015 Apr; 42(4):363-6. PubMed ID: 25656976 [TBL] [Abstract][Full Text] [Related]
17. Topical timolol solution versus laser in treatment of infantile hemangioma: a comparative study. Tawfik AA; Alsharnoubi J Pediatr Dermatol; 2015; 32(3):369-76. PubMed ID: 25740672 [TBL] [Abstract][Full Text] [Related]
18. Iris hemangioma of the newborn: Regression after topical timolol. Izquierdo-Serra J; Dotti-Boada M; Carreras AC; Sanchez-Tinajero CV; Roca MF; Ballús MM J Fr Ophtalmol; 2020 Feb; 43(2):e69-e71. PubMed ID: 31870668 [No Abstract] [Full Text] [Related]
19. Fractional carbon dioxide laser-assisted drug delivery of topical timolol solution for the treatment of deep infantile hemangioma: a pilot study. Ma G; Wu P; Lin X; Chen H; Hu X; Jin Y; Qiu Y Pediatr Dermatol; 2014; 31(3):286-91. PubMed ID: 24602019 [TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of topical timolol treatment of infantile haemangioma: a prospective trial. Borok J; Gangar P; Admani S; Proudfoot J; Friedlander SF Br J Dermatol; 2018 Jan; 178(1):e51-e52. PubMed ID: 28771668 [No Abstract] [Full Text] [Related] [Next] [New Search]